Table of Contents
Pathology Research International
Volume 2013, Article ID 920972, 12 pages
http://dx.doi.org/10.1155/2013/920972
Research Article

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis

1Laboratory of Recognition and Biological Activity Assays, Department of Quality Control, Center of Molecular Immunology, P.O. Box 16040, 216 Street and 15 Avenue Atabey, Playa, 11600 Havana, Cuba
2Department of Cell Biology and Tissues Banking, National Institute of Oncology and Radiobiology, 29 and F Street Vedado, Plaza de la Revolución, 10400 Havana, Cuba
3Department of Pathology, Manuel Fajardo General Hospital, Zapata and D Street Vedado, Plaza de la Revolución, 10400 Havana, Cuba
4Clinical Trials Unit, National Institute of Oncology and Radiobiology, 29 and F Street Vedado, Plaza de la Revolución, 10400 Havana, Cuba
5Department of Pathology, National Institute of Oncology and Radiobiology, 29 and F Street Vedado, Plaza de la Revolución, 10400 Havana, Cuba
6Research and Development Direction, Center of Molecular Immunology, P.O. Box 16040, 216 Street and 15 Avenue Atabey, Playa, 11600 Havana, Cuba

Received 31 July 2013; Revised 30 September 2013; Accepted 10 October 2013

Academic Editor: Shahid Pervez

Copyright © 2013 Rancés Blanco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Rancés Blanco, Damián Blanco, Yisel Quintana, et al., “Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis,” Pathology Research International, vol. 2013, Article ID 920972, 12 pages, 2013. https://doi.org/10.1155/2013/920972.